Human Investing LLC Regeneron Pharmaceuticals, Inc. Transaction History

Human Investing LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$472.8 - $558.54 $69,501 - $82,105	-147 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $1,340 - $1,644	3 Added 2.08%	147 $70,000
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $2,391 - $3,039	-5 Reduced 3.36%	144 $70,000
Q3 2020 Oct 27, 2020	BUY	$544.75 - $658.21 $45,759 - $55,289	84 Added 129.23%	149 $83,000
Q2 2020 Jul 22, 2020	SELL	$493.32 - $643.92 $25,652 - $33,483	-52 Reduced 44.44%	65 $41,000
Q1 2020 Apr 22, 2020	BUY	$336.18 - $494.43 $21,179 - $31,149	63 Added 116.67%	117 $57,000
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $14,803 - $20,331	54 New	54 $20,000

1,530

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

Stay updated on Human Investing LLC with notifications on news.